Company Information
ISIN Code
PK0001301016
Sector
PHARMACEUTICALS
Industry
PHARMACEUTICALS
CEO
Erum Shakir Rahim
Website
Phone
922132315478
Company Size
1,708 employees
Address
35 - Dockyard Road, West Wharf, Karachi
About the Company
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).
Employee History
| Year | Number of Employees |
|---|---|
| 2024 | 1,690 |
| 2023 | 1,708 |
| 2022 | 1,635 |
| 2021 | 1,771 |
Recent Announcements (Last 6 Months)
| Date | Title | Attachments |
|---|---|---|
| 2025-10-16 | Notice of Board of Directors Meeting (Q3-2025) | Image PDF |
| 2025-10-24 | Financial Results for the Quarter ended September 30, 2025 | Image PDF |
| 2025-10-29 | Transmission of Quarterly Report for the period ended September 30, 2025 | Image PDF |
| 2025-12-03 | Notice of Corporate Briefing Session - 2025 | Image PDF |
| 2025-12-05 | Presentation for Corporate Briefing Session -2025 | Image PDF |
| 2026-03-18 | Board Meeting Quarter 4, 2025 | Image PDF |
Financial Reports (Current Year)
Insider Transactions
Price History (Last 30 Days)
| Date | Price (Rs.) | Volume | Market Cap |
|---|---|---|---|
| 2026-03-19 | 316.79 | 290.95K | 100.89B |
| 2026-03-18 | 321.49 | 131.42K | 102.38B |
| 2026-03-17 | 308.82 | 77.47K | 98.35B |
| 2026-03-16 | 312.58 | 247K | 99.55B |
| 2026-03-13 | 319.43 | 266.19K | 101.73B |
| 2026-03-12 | 323.06 | 82.37K | 102.88B |
| 2026-03-11 | 322.28 | 351.98K | 102.64B |
| 2026-03-10 | 318.92 | 141.67K | 101.57B |
| 2026-03-09 | 293.09 | 175.83K | 93.34B |
| 2026-03-06 | 325.66 | 182.26K | 103.71B |
| 2026-03-05 | 340.92 | 79.45K | 108.57B |
| 2026-03-04 | 333.42 | 92.19K | 106.18B |
| 2026-03-03 | 336.70 | 285.97K | 107.23B |
| 2026-03-02 | 335.36 | 318.88K | 106.8B |
| 2026-02-27 | 372.62 | 105.97K | 118.67B |
| 2026-02-26 | 378.06 | 264.49K | 120.4B |
| 2026-02-25 | 382.36 | 87.53K | 121.77B |
| 2026-02-24 | 390.11 | 94.54K | 124.24B |
| 2026-02-23 | 387.46 | 77.8K | 123.39B |
| 2026-02-20 | 395.00 | 96.01K | 125.79B |
| 2026-02-19 | 384.62 | 187.07K | 122.49B |
| 2026-02-18 | 407.00 | 136.01K | 129.62B |